Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

 

 

 

 

Date of Report (Date of earliest event reported)    

  October 6, 2004

 

 

 

Arrowhead Research Corporation
(Exact name of registrant as specified in its charter)

 

 

Delaware   0-21898   46-0408024

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

1118 East Green Street, Pasadena, CA   91106
(Address of principal executive offices)   (Zip Code)

 

 

Registrant’s telephone number, including area code       (626) 792-5549

 

 

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01. Other Event.

 

On October 6, 2004, Arrowhead Research Corporation hosted a conference call. The conference call was announced by press release dated October 5, 2004. The transcript of the conference call is attached hereto as exhibit 99.1 hereto.

 

Item 9.01. Financial Statements and Exhibits.

 

(c) Exhibits.

 

Exhibit No.

 

Description


99.1   Transcript of Investor Conference Call held on October 6, 2004.

 

2


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 8, 2004

 

ARROWHEAD RESEARCH CORPORATION

By:

 

/s/ Joseph T. Kingsley


    Joseph T. Kingsley, Chief Financial Officer

 

3